PPIs are prescribed very frequently and might cause potentially severe hypomagnesaemia. We carried out a study focussing on the prevalence of hypomagnesaemia in geriatric inpatients using PPI and evaluated risk factors contributing to this effect.…
ID
Bron
Aandoening
hypomagnesaemia and PPI use
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
The prevalence of hypomagnesaemia in hospitalised patients using a PPI in a geriatric ward
Achtergrond van het onderzoek
PPIs are prescribed very frequently and might cause potentially severe hypomagnesaemia. We will carry out a study focussing on the prevalence of hypomagnesaemia in geriatric inpatients using PPI and evaluated risk factors contributing to this effect. Mortality and length of hospital admission were also explored.
METHODS: This observational, retrospective cohort study was designed to examine the association between PPI and hypomagnesaemia in geriatric inpatients, identify independent predictors for proton-pump-inhibitor-induced hypomagnesaemia (PPIIH) and explore its effects on mortality and length of hospital admission.
Doel van het onderzoek
PPIs are prescribed very frequently and might cause potentially severe hypomagnesaemia. We carried out a study focussing on the prevalence of hypomagnesaemia in geriatric inpatients using PPI and evaluated risk factors contributing to this effect. Mortality and length of hospital admission were also explored
Onderzoeksopzet
not applicable
Onderzoeksproduct en/of interventie
not applicable
Publiek
Carolina Keijsers
Den Bosch 5200 ME
The Netherlands
k.keijsers@jbz.nl
Wetenschappelijk
Carolina Keijsers
Den Bosch 5200 ME
The Netherlands
k.keijsers@jbz.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
- Admission in the geriatric ward in Jeroen Bosch Hospital between August 1st, 2014 and April 30th, 2017. This start date was chosen because since then magnesium was included in the regular laboratory examination.
- Magnesium serum levels determined in venous blood must be known.
- Medication prescribed before and during admission must be known.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
- Age below 65 years.
- Patients with re-admissions, since all patients are included once in this research.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL6257 |
NTR-old | NTR6431 |
Ander register | JBZ study number : 2017.05.02.01 |